SDIC
South Dakota Investment Council Portfolio holdings
AUM
$5.22B
1-Year Return
11.75%
This Quarter Return
+11.01%
1 Year Return
+11.75%
3 Year Return
+59.88%
5 Year Return
+138.34%
10 Year Return
+253.47%
AUM
$4.79B
AUM Growth
-$321M
(-6.3%)
Cap. Flow
-$828M
Cap. Flow
% of AUM
-17.29%
Top 10 Holdings %
Top 10 Hldgs %
30.42%
Holding
631
New
12
Increased
42
Reduced
441
Closed
45
Top Buys
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$211M |
| 2 |
Becton Dickinson
BDX
|
+$13.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$12.6M |
| 4 |
Expedia Group
EXPE
|
+$7.06M |
| 5 |
Viatris
VTRS
|
+$4.85M |
Top Sells
| 1 |
Apple
AAPL
|
+$59.6M |
| 2 |
CELG
Celgene Corp
CELG
|
+$47.2M |
| 3 |
Microsoft
MSFT
|
+$38.9M |
| 4 |
Meta Platforms (Facebook)
META
|
+$25.7M |
| 5 |
Lam Research
LRCX
|
+$19.4M |
Sector Composition
| 1 | Financials | 13.67% |
| 2 | Healthcare | 13.38% |
| 3 | Technology | 12.45% |
| 4 | Energy | 8.96% |
| 5 | Consumer Discretionary | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
B&G Foods
BGS
$369M
| $296K | 0.01% |
16,500
| – | – |
|
527
WD-40
WDFC
$2.88B
| $293K | 0.01% |
1,510
| – | – |
|
|
BGG
528
DELISTED
Briggs & Stratton Corp.
BGG
| $284K | 0.01% |
42,570
| – | – |
|
529
Lantheus
LNTH
$3.74B
| $279K | 0.01% |
13,600
| – | – |
|
530
The Ensign Group
ENSG
$9.75B
| $277K | 0.01% |
6,100
-421
| -6% | -$19.1K |
|
531
Microchip Technology
MCHP
$35.1B
| $272K | 0.01% |
5,200
-3,800
| -42% | -$199K |
|
532
Medpace
MEDP
$14B
| $269K | 0.01% |
3,200
| – | – |
|
533
Sysco
SYY
$38.8B
| $269K | 0.01% |
3,150
-23,780
| -88% | -$2.03M |
|
534
Nu Skin
NUS
$579M
| $268K | 0.01% |
6,540
| – | – |
|
|
SPPI
535
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $254K | 0.01% |
69,800
| – | – |
|
536
Merit Medical Systems
MMSI
$5.34B
| $237K | ﹤0.01% |
7,600
| – | – |
|
537
Coca-Cola Consolidated
COKE
$10.8B
| $230K | ﹤0.01% |
8,100
| – | – |
|
538
Flotek Industries
FTK
$339M
| $228K | ﹤0.01% |
19,014
| – | – |
|
539
ICU Medical
ICUI
$3.33B
| $225K | ﹤0.01% |
1,200
| – | – |
|
540
Inogen
INGN
$231M
| $225K | ﹤0.01% |
3,300
| – | – |
|
541
Cal-Maine
CALM
$5.38B
| $222K | ﹤0.01% |
5,200
-1,800
| -26% | -$76.8K |
|
542
NeoGenomics
NEO
$1.08B
| $214K | ﹤0.01% |
7,300
| – | – |
|
543
Regenxbio
RGNX
$479M
| $213K | ﹤0.01% |
5,200
| – | – |
|
544
Estee Lauder
EL
$31.2B
| $207K | ﹤0.01% |
1,000
-500
| -33% | -$104K |
|
545
Avanos Medical
AVNS
$576M
| $202K | ﹤0.01% |
6,000
| – | – |
|
546
Leidos
LDOS
$23.8B
| $199K | ﹤0.01% |
2,030
-23,010
| -92% | -$2.26M |
|
547
SpartanNash
SPTN
$898M
| $199K | ﹤0.01% |
13,950
-131,580
| -90% | -$1.88M |
|
548
PPG Industries
PPG
$25.2B
| $191K | ﹤0.01% |
1,430
-10,850
| -88% | -$1.45M |
|
|
VIVO
549
DELISTED
Meridian Bioscience Inc
VIVO
| $187K | ﹤0.01% |
19,100
| – | – |
|
550
Tactile Systems Technology
TCMD
$306M
| $182K | ﹤0.01% |
+2,700
| New | +$182K |
|